Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
|
CN |
|
D
|
Delta Paint PCL
SET:DPAINT
|
TH |
|
Mahindra EPC Irrigation Ltd
NSE:MAHEPC
|
IN |
|
M
|
Marston's PLC
XBER:WVDA
|
UK |
|
B
|
Blessed Assets Group Co Ltd PCL
SET:BLESS
|
TH |
|
Workman Co Ltd
TSE:7564
|
JP |
|
M
|
MyMD Pharmaceuticals Inc
NASDAQ:MYMD
|
US |
|
OMV AG
F:OMVI
|
AT |
|
H
|
Huuuge Inc
WSE:HUG
|
US |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shenzhen Chipscreen Biosciences Co Ltd's stock price target?
Not Available
Shenzhen Chipscreen Biosciences Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Shenzhen Chipscreen Biosciences Co Ltd?
Projected CAGR
49%
Over the last 8 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 2 years is 49%.
What is the Operating Income forecast for Shenzhen Chipscreen Biosciences Co Ltd?
Projected CAGR
77%
Over the last 8 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 2 years is 77%.
What is the Pre-Tax Income forecast for Shenzhen Chipscreen Biosciences Co Ltd?
Projected CAGR
217%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 2 years is 217%.
What is the Net Income forecast for Shenzhen Chipscreen Biosciences Co Ltd?
Projected CAGR
190%
Over the last 8 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 190%.
